Medicine and Dentistry
Assay
100%
Patient
62%
COVID-19
55%
Severe Acute Respiratory Syndrome Coronavirus 2
54%
Neutralizing Antibody
44%
Blood Stasis
44%
Laboratory
42%
Antibody
34%
Plasma
33%
Coagulation
32%
Vaccine
29%
Thrombin
29%
Direct Oral Anticoagulant
28%
Infection
28%
Assessment
26%
Activated Protein C Resistance
23%
Diagnosis
22%
Woman
22%
Heparin
22%
Antigen
21%
Immunoglobulin G
18%
Apixaban
17%
Thrombosis
17%
Inpatient
17%
Anticoagulation
17%
In Vitro
17%
Estetrol
16%
Monitoring
15%
Protein
15%
Measurement
15%
Antibody Response
14%
Therapeutic Procedure
13%
Cells
13%
Analysis
13%
Humoral Immunity
13%
Rivaroxaban
13%
COVID-19 Vaccination
12%
Virus
11%
Oral Contraceptive
11%
Betrixaban
11%
Drospirenone
10%
Tyrosine-Kinase Inhibitor
10%
Syndrome
10%
Thrombocytopenia
10%
Cell Survival
10%
Cell Function
10%
Endothelial Cell
10%
Blood Clotting Factor 10a Inhibitor
10%
Antithrombotic
10%
Partial Thromboplastin Time
10%
Pharmacology, Toxicology and Pharmaceutical Science
Direct Oral Anticoagulant
84%
Anticoagulant Agent
58%
Rivaroxaban
55%
Dabigatran
49%
Heparin
34%
Apixaban
33%
Antivitamin K
31%
Dabigatran Etexilate
31%
Bleeding
30%
Thrombin
30%
Atrial Fibrillation
29%
Protein Tyrosine Kinase Inhibitor
27%
Thromboplastin
26%
Blood Clotting Factor 10a Inhibitor
26%
Prothrombin
22%
Thrombin Inhibitor
20%
Thromboembolism
19%
Drug
19%
Reagent
19%
Chronic Myeloid Leukemia
18%
Low Molecular Weight Heparin
17%
Daboia russellii
16%
Viper Venom
16%
Emergency
16%
Warfarin
16%
Ponatinib
15%
Edoxaban
15%
Clotting Time
14%
Nilotinib
14%
Dasatinib
13%
Diseases
13%
Betrixaban
13%
SARS Coronavirus
11%
Coronavirinae
11%
Survival
11%
Activated Protein C Resistance
11%
Estetrol
10%
Prospective Study
10%
Pharmacodynamics
10%
Pharmacokinetics
10%
Thrombosis
9%
Venous Thromboembolism
9%
Blood Clotting Disorder
8%
Ensure
8%
Toxic Injury
8%
Antigen
8%
Inflammation
8%
Idarucizumab
7%
Drug Interaction
7%
Heart Infarction
7%
Biochemistry, Genetics and Molecular Biology
Thrombin
54%
Coagulation
49%
Sample
44%
SARS Coronavirus
37%
Hemostasis
32%
Time
23%
Blood Level
23%
Partial Thromboplastin Time
22%
Antibody
21%
Prothrombin Time
19%
Heparin
17%
Taxonomy
16%
D-Dimer
16%
Rivaroxaban
15%
Anticoagulation
15%
Activated Protein C Resistance
11%
Thrombin Time
11%
Nucleosome
10%
Tyrosine Kinase Inhibitor
10%
Immunoglobulin M
10%
Antithrombin
10%
Kinetics
10%
Reverse Transcription Polymerase Chain Reaction
9%
Dose
9%
Fibrinogen
8%
Coronavirinae
8%
Virus Load
8%
Fibrinolysis
7%
Immunoglobulin G
7%
Laboratory Test
7%
Myeloid
6%
Electric Potential
6%
Overall Survival
6%
Ponatinib
6%
Viperinae
6%
Histone
5%
Protein S
5%
Relapse
5%
Posttranslational Modification
5%
Tandem Mass Spectrometry
5%
Quantitative Technique
5%
Cell Survival
5%
Association
5%
All Cause Mortality
5%
Molecular Array
5%
Laboratory Technique
5%
Neutralizing Antibody
5%
Recognition
5%
Immunoglobulin G
5%
Cell Function
5%